139 related articles for article (PubMed ID: 17417999)
1. Pulmonary sarcoidosis in a patient with ankylosing spondylitis treated with infliximab.
Almodóvar R; Izquierdo M; Zarco P; Javier Quirós F; Mazzucchelli R; Steen B
Clin Exp Rheumatol; 2007; 25(1):99-101. PubMed ID: 17417999
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of ankylosing spondylitis coexisting with pulmonary sarcoidosis by infliximab.
Ochi S; Nanki T; Kaneko H; Honne K; Miyazaki Y; Komano Y; Miyasaka N
Clin Exp Rheumatol; 2009; 27(4):698-9. PubMed ID: 19772811
[No Abstract] [Full Text] [Related]
3. Pulmonary sarcoidosis developing during infliximab therapy.
O'Shea FD; Marras TK; Inman RD
Arthritis Rheum; 2006 Dec; 55(6):978-81. PubMed ID: 17139647
[No Abstract] [Full Text] [Related]
4. Infliximab induced skin and pulmonary sarcoidosis in a rheumatoid arthritis patient.
Josse S; Klemmer N; Moreno-Swirc S; Goëb V; Lequerré T; Vittecoq O
Joint Bone Spine; 2009 Dec; 76(6):718-9. PubMed ID: 19464223
[No Abstract] [Full Text] [Related]
5. Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy.
Izzi S; Francesconi F; Visca P; Altieri A; De Mutiis C; Trevisan G; Bonifati C
Dermatol Online J; 2010 May; 16(5):16. PubMed ID: 20492833
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced lupus-like syndrome in ankylosing spondylitis treated with infliximab.
Mounach A; Ghazi M; Nouijai A; Ghozlani I; Achemlal L; Bezza A; El Maghraoui A
Clin Exp Rheumatol; 2008; 26(6):1116-8. PubMed ID: 19210883
[TBL] [Abstract][Full Text] [Related]
7. Sézary syndrome in a patient receiving infliximab for ankylosing spondylitis.
Dauendorffer JN; Rivet J; Allard A; Bachelez H
Br J Dermatol; 2007 Apr; 156(4):742-3. PubMed ID: 17263820
[TBL] [Abstract][Full Text] [Related]
8. Infliximab-induced lupus-like syndrome in a patient with ankylosing spondylitis.
Bodur H; Eser F; Konca S; Arikan S
Rheumatol Int; 2009 Feb; 29(4):451-4. PubMed ID: 18712523
[TBL] [Abstract][Full Text] [Related]
9. Acquired erythrocytosis upon treatment with infliximab for ankylosing spondylitis.
Antonelli M; Bupathi M; Janakiram M; Hergenroeder P; Khan MA
J Rheumatol; 2011 Mar; 38(3):581-3. PubMed ID: 21362796
[No Abstract] [Full Text] [Related]
10. Paraparesis due to exacerbation of preexisting spinal pseudoarthrosis following infliximab therapy for advanced ankylosing spondylitis.
Sakaura H; Hosono N; Mukai Y; Fujii R; Yoshikawa H
Spine J; 2006; 6(3):325-9. PubMed ID: 16651229
[TBL] [Abstract][Full Text] [Related]
11. [A case of generalized tuberculosis in the use of infliximab (Remicade) in patients with Bekhterev's disease].
Nekrasov EV; Strelis AK; Ianova GV; Filiniuk OV; Buĭnova LN
Tuberk Biolezni Legkih; 2009; (8):56-60. PubMed ID: 19803353
[No Abstract] [Full Text] [Related]
12. Exacerbation of infliximab-induced palmoplantar psoriasis under ustekinumab therapy in a patient with ankylosing spondylitis.
Safa G; Martin A; Darrieux L
J Clin Rheumatol; 2011 Oct; 17(7):385-6. PubMed ID: 21946468
[No Abstract] [Full Text] [Related]
13. Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial.
Braun J; Brandt J; Listing J; Zink A; Alten R; Burmester G; Golder W; Gromnica-Ihle E; Kellner H; Schneider M; Sörensen H; Zeidler H; Reddig J; Sieper J
Arthritis Rheum; 2003 Aug; 48(8):2224-33. PubMed ID: 12905476
[TBL] [Abstract][Full Text] [Related]
14. Alveolar hemorrhage after infliximab therapy.
Jeannin G; Mathieu S; Kemeny JL; Caillaud D; Soubrier M
Joint Bone Spine; 2010 Mar; 77(2):189-90. PubMed ID: 20171918
[No Abstract] [Full Text] [Related]
15. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).
van der Heijde D; Dijkmans B; Geusens P; Sieper J; DeWoody K; Williamson P; Braun J;
Arthritis Rheum; 2005 Feb; 52(2):582-91. PubMed ID: 15692973
[TBL] [Abstract][Full Text] [Related]
16. Mycosis fungoides in a patient with ankylosing spondylitis during infliximab therapy.
Sanli H; Ataman S; Akay BN; Yilmaz A; Yildizlar D; Gürgey E
J Drugs Dermatol; 2007 Aug; 6(8):834-6. PubMed ID: 17763616
[TBL] [Abstract][Full Text] [Related]
17. Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response.
Braun J; Baraliakos X; Listing J; Fritz C; Alten R; Burmester G; Krause A; Schewe S; Schneider M; Sörensen H; Zeidler H; Sieper J
Ann Rheum Dis; 2008 Mar; 67(3):340-5. PubMed ID: 17967831
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced systemic lupus erythematosus in ankylosing spondylitis associated with infliximab.
Pérez-García C; Maymo J; Lisbona Pérez MP; Almirall Bernabé M; Carbonell Abelló J
Rheumatology (Oxford); 2006 Jan; 45(1):114-6. PubMed ID: 16319096
[No Abstract] [Full Text] [Related]
19. Fertility and reproduction in male patients with ankylosing spondylitis treated with infliximab.
Paschou S; Voulgari PV; Vrabie IG; Saougou IG; Drosos AA
J Rheumatol; 2009 Feb; 36(2):351-4. PubMed ID: 19040305
[TBL] [Abstract][Full Text] [Related]
20. Infliximab-induced palmoplantar psoriasis in a patient with ankylosing spondylitis.
Capkin E; Karkucak M; Yayli S; Aydin Çapkin A; Tosun M
J Clin Rheumatol; 2011 Aug; 17(5):293-4. PubMed ID: 21808187
[No Abstract] [Full Text] [Related]
[Next] [New Search]